ロード中...
Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease
BACKGROUND: A three-drug regimen (macrolide, ethambutol, and rifampicin) is recommended for the treatment of Mycobacterium avium complex pulmonary disease (MAC-PD). Although macrolide has proven efficacy, the role of ethambutol and rifampicin in patients without acquired immune deficiency syndrome i...
保存先:
| 出版年: | BMC Pulm Med |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6849249/ https://ncbi.nlm.nih.gov/pubmed/31711459 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-019-0982-8 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|